ArticleJournal of bone and mineral metabolism2026
Treatment-dependent association between sarcopenia and ADL at discharge after osteoporotic vertebral fractures.
Article in Journal of bone and mineral metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSarcopenia has been associated with lower activities of daily living (ADL). This study investigated whether sarcopenia at admission is associated with ADL at discharge in patients with osteoporotic vertebral fractures (OVF) and whether this differs by treatment (conservative or balloon kyphoplasty, BKP). MATERIALS AND
methodsThis prospective cohort study included 78 patients with OVF (76.8% female; mean age 83.0 ± 6.7 years). Sarcopenia was defined according to the 2019 Asian Working Group for Sarcopenia criteria, requiring low skeletal muscle mass and low handgrip strength. The outcome was ADL at discharge. Multivariate regression analyses were performed after adjusting for age, sex, mini-mental state examination (MMSE), functional independence measure (FIM-M) at admission, and geriatric nutritional risk index (GNRI). An interaction term (sarcopenia × treatment) was included to examine treatment-dependent associations.
resultsMultivariate analysis revealed a significant association between sarcopenia at admission and lower FIM-M at discharge (B = - 11.77, β = - 0.36, 95% CI = - 20.47 to - 3.07, P = 0.009). A significant interaction between sarcopenia and treatment was also detected (B = 5.81, β = 0.40, 95% CI = 0.02 to 11.60, P = 0.049), indicating that the association between sarcopenia and FIM-M at discharge differed with treatment modality.
conclusionSarcopenia at admission correlated with ADL at discharge in patients with OVF. This association was modified by treatment modality, with the negative association attenuated in patients undergoing BKP.
Indexed as
Identifiers
42828582What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.